Capstone Asset Management Co. boosted its position in Stryker Corp. (NYSE:SYK) by 3.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 44,209 shares of the medical technology company’s stock after buying an additional 1,435 shares during the period. Capstone Asset Management Co.’s holdings in Stryker Corp. were worth $5,146,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the company. Meag Munich Ergo Kapitalanlagegesellschaft MBH increased its stake in shares of Stryker Corp. by 444.7% in the second quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 165,225 shares of the medical technology company’s stock worth $19,667,000 after buying an additional 134,892 shares during the last quarter. Ngam Advisors L.P. increased its stake in shares of Stryker Corp. by 217.3% in the second quarter. Ngam Advisors L.P. now owns 77,132 shares of the medical technology company’s stock worth $9,243,000 after buying an additional 52,821 shares during the last quarter. Acadian Asset Management LLC increased its stake in shares of Stryker Corp. by 376,330.6% in the second quarter. Acadian Asset Management LLC now owns 135,515 shares of the medical technology company’s stock worth $16,238,000 after buying an additional 135,479 shares during the last quarter. Huntington National Bank increased its stake in shares of Stryker Corp. by 36.4% in the second quarter. Huntington National Bank now owns 158,939 shares of the medical technology company’s stock worth $19,046,000 after buying an additional 42,423 shares during the last quarter. Finally, Polaris Greystone Financial Group LLC increased its stake in shares of Stryker Corp. by 11.8% in the second quarter. Polaris Greystone Financial Group LLC now owns 130,979 shares of the medical technology company’s stock worth $15,695,000 after buying an additional 13,813 shares during the last quarter. Hedge funds and other institutional investors own 74.90% of the company’s stock.

Institutional Ownership by Quarter for Stryker Corp. (NYSE:SYK)

Stryker Corp. (NYSE:SYK) traded up 0.10% during mid-day trading on Monday, reaching $112.95. 1,297,368 shares of the company traded hands. The stock has a market capitalization of $42.29 billion, a price-to-earnings ratio of 25.71 and a beta of 0.86. Stryker Corp. has a 12-month low of $86.68 and a 12-month high of $123.55. The company’s 50-day moving average is $113.60 and its 200-day moving average is $115.00.

Stryker Corp. (NYSE:SYK) last posted its quarterly earnings results on Thursday, October 27th. The medical technology company reported $1.39 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.37 by $0.02. Stryker Corp. had a return on equity of 23.61% and a net margin of 15.24%. The company had revenue of $2.83 billion for the quarter, compared to analysts’ expectations of $2.81 billion. During the same period last year, the firm earned $1.25 earnings per share. Stryker Corp.’s quarterly revenue was up 17.1% on a year-over-year basis. Equities analysts predict that Stryker Corp. will post $5.78 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Capstone Asset Management Co. Has $5,146,000 Stake in Stryker Corp. (SYK)” was originally posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright & trademark law. The correct version of this article can be viewed at https://www.thecerbatgem.com/2016/11/28/capstone-asset-management-co-has-5146000-stake-in-stryker-corp-syk.html.

SYK has been the topic of a number of analyst reports. Zacks Investment Research upgraded shares of Stryker Corp. from a “sell” rating to a “hold” rating and set a $129.00 price objective on the stock in a research note on Monday, October 31st. BMO Capital Markets raised shares of Stryker Corp. from an “underperform” rating to a “market perform” rating and set a $125.00 target price for the company in a report on Tuesday, November 1st. They noted that the move was a valuation call. SunTrust Banks Inc. started coverage on shares of Stryker Corp. in a report on Thursday, October 13th. They issued a “buy” rating and a $140.00 target price for the company. Needham & Company LLC reissued a “hold” rating on shares of Stryker Corp. in a report on Sunday, November 13th. Finally, Canaccord Genuity set a $127.00 target price on shares of Stryker Corp. and gave the stock a “buy” rating in a report on Sunday, October 30th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $122.38.

In other news, VP Yin C. Becker sold 1,111 shares of Stryker Corp. stock in a transaction dated Thursday, October 6th. The stock was sold at an average price of $117.00, for a total transaction of $129,987.00. Following the sale, the vice president now owns 16,939 shares in the company, valued at $1,981,863. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Yin C. Becker sold 12,000 shares of Stryker Corp. stock in a transaction dated Wednesday, October 12th. The stock was sold at an average price of $114.03, for a total value of $1,368,360.00. Following the sale, the vice president now owns 28,939 shares in the company, valued at approximately $3,299,914.17. The disclosure for this sale can be found here. 7.80% of the stock is owned by company insiders.

About Stryker Corp.

Stryker Corporation (Stryker) is a medical technology company. The Company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Company’s Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries. The Company’s MedSurg segment products consist of surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical), and reprocessed and remanufactured medical devices (Sustainability), as well as other medical device products used in a range of medical specialties.

5 Day Chart for NYSE:SYK

Receive News & Stock Ratings for Stryker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corp. and related stocks with our FREE daily email newsletter.